Alex Therapeutics
PrivateLast Round
Series A
Mar 3, 2023
Total Funding Raised
$9.24M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Alex Therapeutics is a healthtech company that develops and licenses clinically validated digital therapeutics (DTx) and companion apps in partnership with pharmaceutical companies.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Patient Engagement, Vertical SaaS, Compliance
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alex Therapeutics Comparables
Compare Alex Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dawn Health | 83% | |
| Amalgam Rx | 80% | |
| BrightInsight | 79% | |
Alex Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 3, 2023 | ||||
| Series A | Apr 6, 2022 | ||||
| Grant | Jun 4, 2021 | ||||
| Seed | Jul 23, 2018 |
Key People
Founding team and executive leadership
Alex Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovestor | Series A |
| Vinnova | Grant |
| Bonit Capital | Series A |
| South Bay Ventures | Series A |
| Sweet Studio | Series A, Seed |
| Hadean Ventures | Series A |
| Scale Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 380% MoM, reaching 1.4K.
- Mar 3, 2023
$5.03M round led by Innovestor.
Alex Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alex Therapeutics's valuation, stock price, and market status.